Mitchell Kaye
Director/Board Member at AEOLUS PHARMACEUTICALS, INC.
Mitchell Kaye active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 2013-05-07 | - |
| Independent Dir/Board Member | 2013-05-07 | - | |
| Xmark Fund Ltd. | Chief Investment Officer | 2000-12-31 | - |
| Sabbatical Ventures LLC | Founder | - | - |
| Corporate Officer/Principal | - | - |
Career history of Mitchell Kaye
Former positions of Mitchell Kaye
| Companies | Position | Start | End |
|---|---|---|---|
| BIONOMICS LIMITED | Director/Board Member | 2018-11-22 | 2021-12-30 |
| Independent Dir/Board Member | 2018-11-22 | 2021-12-30 | |
Health Revenue Assurance Holdings, Inc.
 Health Revenue Assurance Holdings, Inc. Services to the Health IndustryHealth Services Health Revenue Assurance Holdings, Inc. engages in the provision of revenue cycle services for healthcare providers. It offers revenue cycle data analysis, contract and outsourced coding, International Classification Disease-10 (ICD) education, and transition services. The company was founded on December 13, 2010 and is headquartered in New York, NY. | Director/Board Member | 2013-11-11 | 2014-04-01 |
MedClaims Liaison LLC
 MedClaims Liaison LLC Insurance Brokers/ServicesFinance MedClaims Liaison LLC provides healthcare reimbursement services. The private company is based in Ridgefield, CT. The company was founded in 2009 by Mitchell D. Kaye, Nancy Kaye. | Chief Executive Officer | 2008-12-31 | - |
| Founder | 2008-12-31 | - | |
Navigant Capital Advisors LLC
 Navigant Capital Advisors LLC Investment ManagersFinance Navigant Capital Advisors LLC provides investment banking services. It offers fairness opinion, mergers and acquisition, private placement, due diligence, divestiture, leveraged recapitalization and refinancing, debt and equity underwriting and business turnaround advisory services. The company is headquartered in Chicago, IL. | Corporate Officer/Principal | 2007-12-31 | 2009-12-31 |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Director/Board Member | 2007-08-31 | 2009-07-12 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Director/Board Member | 2006-02-27 | 2007-05-01 |
| ░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Mitchell Kaye
| Wesleyan University | Undergraduate Degree |
| Northwestern University School of Law | Graduate Degree |
Statistics
International
| United States | 14 |
| Canada | 2 |
| Australia | 2 |
Operational
| Director/Board Member | 7 |
| Corporate Officer/Principal | 4 |
| Chief Investment Officer | 2 |
Sectoral
| Finance | 6 |
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BIONOMICS LIMITED | Health Technology |
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Guidehouse, Inc. (Virginia)
 Guidehouse, Inc. (Virginia) Miscellaneous Commercial ServicesCommercial Services Guidehouse, Inc. provides advisory, consulting, outsourcing, technology, and analytics services. It also offers data and analytics, digital enterprise, operations consulting, revenue cycle, risk and compliance, sustainability solutions, and transformation solutions. The company was founded in 1996 and is headquartered in Chicago, IL. | Commercial Services |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Finance |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
Xmark Opportunity Partners LLC
 Xmark Opportunity Partners LLC Investment ManagersFinance Founded in 2001 by Mitchell Kaye, Xmark Opportunity Partners LLC is a hedge fund company located in Ridgefield, Connecticut | Finance |
MedClaims Liaison LLC
MedClaims Liaison LLC Insurance Brokers/ServicesFinance MedClaims Liaison LLC provides healthcare reimbursement services. The private company is based in Ridgefield, CT. The company was founded in 2009 by Mitchell D. Kaye, Nancy Kaye. | Finance |
| Sabbatical Ventures LLC | |
| Xmark Fund Ltd. | |
| Xmark Asset Management LLC | Finance |
Navigant Capital Advisors LLC
Navigant Capital Advisors LLC Investment ManagersFinance Navigant Capital Advisors LLC provides investment banking services. It offers fairness opinion, mergers and acquisition, private placement, due diligence, divestiture, leveraged recapitalization and refinancing, debt and equity underwriting and business turnaround advisory services. The company is headquartered in Chicago, IL. | Finance |
Health Revenue Assurance Holdings, Inc.
Health Revenue Assurance Holdings, Inc. Services to the Health IndustryHealth Services Health Revenue Assurance Holdings, Inc. engages in the provision of revenue cycle services for healthcare providers. It offers revenue cycle data analysis, contract and outsourced coding, International Classification Disease-10 (ICD) education, and transition services. The company was founded on December 13, 2010 and is headquartered in New York, NY. | Health Services |
| New York Alzheimers Association |
- Stock Market
- Insiders
- Mitchell Kaye
- Experience